Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07288008 · ClinicalTrials.gov registry record · NA

Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study

A NA study of Anxiety, sponsored by Birmingham VA Health Care System.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07288008 is a NA study of Anxiety that is actively recruiting participants, run by Birmingham VA Health Care System. The registered enrollment target is 40 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07288008, a NA study of Anxiety, is actively recruiting participants, sponsored by Birmingham VA Health Care System.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Transcranial alternating current stimulation (tACS) in a wearable brain stimulation device that delivers a low intensity, pulsed, alternating current via scalp electrodes. Prior sham-controlled clinical trials have shown the therapeutic effects and safety of tACS for the treatment of anxiety and depression. In addition, tACS is rapid acting and well tolerated. After the device is issued to the patient during an in-office orientation and training session, the tACS device can be safely used by the patient at the convenience of their own home. Up to 40 Veterans under that age of 70 who have clinically significant anxiety will be enrolled in an 8-week open-label trial of Model FW-200 tACS to evaluate feasibility, acceptability, adherence and impact on anxiety, depression, post-traumatic stress disorder (PTSD), sleep and neurocognitive measures. Participants may have a concurrent diagnosis of major depressive disorder (MDD) and/or PTSD.

Conditions Studied

Anxiety

Interventions

  • DEVICE Transcranial alternating current stimulator

Study Locations (1)

Alabama

  • Birmingham VA - Birmingham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-12-15
Est. Completion 2028-06-30
Phase NA

Sponsor

Birmingham VA Health Care System

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07288008

The ClinicalTrials.gov registry entry for NCT07288008 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The listed sponsor is Birmingham VA Health Care System, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Transcranial alternating current stimulator is the first listed.

NCT07288008 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07288008 about?

NCT07288008 is a clinical study titled "Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study". Transcranial alternating current stimulation (tACS) in a wearable brain stimulation device that delivers a low intensity, pulsed, alternating current via scalp electrodes. Prior sham-controlled clinical trials have shown the therapeutic effects and safety of tACS for the treatment of anxiety and dep...

What is the current status of trial NCT07288008?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-12-15. Estimated completion is 2028-06-30.

What conditions does trial NCT07288008 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT07288008?

The interventions under investigation include: Transcranial alternating current stimulator (DEVICE).

Who is sponsoring clinical trial NCT07288008?

This trial is sponsored by Birmingham VA Health Care System, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07288008 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anxiety

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.